Mirtazapine for anorexia nervosa with depression

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain. Method: We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.Results: The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment. Conclusions: Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients' physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.

Original languageEnglish
Pages (from-to)768-769
Number of pages2
JournalAustralian and New Zealand Journal of Psychiatry
Volume41
Issue number9
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Anorexia Nervosa
Depression
Weight Gain
Body Mass Index
Outpatients
mirtazapine
Therapeutics

Keywords

  • Anorexia nervosa
  • Depression
  • Mirtazapine
  • Weight

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{9629229bb98a478aa8d11f67c413afc3,
title = "Mirtazapine for anorexia nervosa with depression",
abstract = "Objective: To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain. Method: We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.Results: The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment. Conclusions: Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients' physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.",
keywords = "Anorexia nervosa, Depression, Mirtazapine, Weight",
author = "{Nik Jaafar}, {Nik Ruzyanei} and {Mohd Daud}, {Tuti Iryani} and {Abdul Rahman}, {Fairuz Nazri} and Azlin Baharudin",
year = "2007",
month = "9",
doi = "10.1080/00048670701517983",
language = "English",
volume = "41",
pages = "768--769",
journal = "Australian and New Zealand Journal of Psychiatry",
issn = "0004-8674",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Mirtazapine for anorexia nervosa with depression

AU - Nik Jaafar, Nik Ruzyanei

AU - Mohd Daud, Tuti Iryani

AU - Abdul Rahman, Fairuz Nazri

AU - Baharudin, Azlin

PY - 2007/9

Y1 - 2007/9

N2 - Objective: To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain. Method: We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.Results: The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment. Conclusions: Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients' physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.

AB - Objective: To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain. Method: We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.Results: The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment. Conclusions: Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients' physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.

KW - Anorexia nervosa

KW - Depression

KW - Mirtazapine

KW - Weight

UR - http://www.scopus.com/inward/record.url?scp=34547908512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547908512&partnerID=8YFLogxK

U2 - 10.1080/00048670701517983

DO - 10.1080/00048670701517983

M3 - Article

C2 - 17687663

AN - SCOPUS:34547908512

VL - 41

SP - 768

EP - 769

JO - Australian and New Zealand Journal of Psychiatry

JF - Australian and New Zealand Journal of Psychiatry

SN - 0004-8674

IS - 9

ER -